Sana Biotechnology's favorable Phase 1 trial could rapidly re-rate the stock even higher, especially since it targets a ...
Hosted on MSN
Should You Buy Exact Sciences Stock Before Nov. 3?
Exact Sciences' most important product is driving solid revenue growth. It has launched several others that could help boost sales and jolt the stock. The company's long-term prospects look attractive ...
A look at Exact Sciences Corporation’s acquisition by Abbott: review EXAS revenue growth, margins, and CRC/MRD screening ...
Zacks Investment Research on MSN
Gilead Sciences, Inc. (GILD) is a trending stock: Facts to know before betting on it
Gilead Sciences (GILD) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
Abbott made a takeover offer for Exact Sciences. The two companies want to team up to combat cancer. Under the terms of the deal, Exact Sciences' stockholders would receive $105 per share in cash. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback